NPWT group n = 21 | Control group n = 21 | |
---|---|---|
Age, mean | 71 | 69 |
Gender | ||
Male | 19 (90.5) | 13 (62) |
Female | 2 (9.5) | 8 (38) |
BMI classification | ||
< 18 | 0 (0) | 0 (0) |
18–25 | 9 (43) | 8 (38) |
25–30 | 10 (47.5) | 11 (52.5) |
> 30 | 2 (9.5) | 2 (9.5) |
Neoadjuvant radiation | 12 (57) | 12 (57) |
25 Gy | 7 (58) | 7 (58) |
50 Gy with neoadjuvant chemotherapy | 5 (42) | 5 (42) |
Tumor stage T-stage | ||
T0 | 0 (0) | 1 (5) |
T1 | 1 (5) | 1 (5) |
T2 | 7 (33.5) | 6 (28.5) |
T3 | 11 (52) | 11 (52) |
T4 | 2 (9.5) | 2 (9.5) |
Tumor stage N-stage | ||
0 | 7 (33) | 13 (62) |
1 | 3 (14) | |
1a | 3 (14.5) | |
1b | 4 (19) | 1 (5) |
1c | 3 (14.5) | 1 (5) |
2a | 3 (14) | |
2b | 4 (19) | |
Tumor stage M-stage | ||
0 | 20 (95) | 19 (90.5) |
1 | 1 (5) | 2 (9.5) |